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a b s t r a c t
The -subunit of tetrodotoxin-resistant voltage-gated sodium channel NaV1.8 is selectively expressed in
sensory neurons. It has been reported that NaV1.8 is involved in the transmission of nociceptive infor-eceived in revised form 24 August 2010
ccepted 25 August 2010
eywords:
odium Channel
ensory Neuron
mation from sensory neurons to the central nervous system in nociceptive [1] and neuropathic [24] pain
conditions. Thus NaV1.8 has been a promising target to treat chronic pain. Here we discuss the recent
advances in the study of trafﬁcking mechanism of NaV1.8. These pieces of information are particularly
important as such trafﬁcking machinery could be new targets for painkillers.
© 2010 Elsevier Ireland Ltd. Open access under CC BY license. ain
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Membrane proteins are translated in the rough ER, post-
ranslationally modiﬁed and sorted during their migration through
he Golgi to the plasma membrane. Interestingly, a large sub-
opulation of voltage-gated sodium channels are not directly
ranslocated to theplasmamembrane, but stored in ametabolically
table ‘intracelluar pool’ of folded protein [36]. This pool may per-
it the neuron to respond rapidly to stimuli, allowing it to increase
hannel surface density faster than de novo synthesis would oth-
rwise allow. Recent reports describe many novel mechanisms
hich regulate the trafﬁcking of ion channels to the plasma mem-
rane occurring at many points along the pathway including the
nitial translation and folding, subsequent post-translational mod-
ﬁcation e.g. N-glycosylation and palmitylation and by numerous
1. ER retention signals
The RXR motif, which serves as an ER retention signal, is found
in many membrane proteins, including ATP-sensitive potassium
channels [53], NMDA [40] and GABAB receptors [12]. NaV1.8 pos-
sesses at least one functional ER retention signal within the ﬁrst
intracellular loop, consisting of residues RRR495–497 [54]. Substi-
tution of this motif with alanines results in an increased expression
of the channel on the membrane. The mechanism behind NaV1.8
release from the ER and trafﬁcking to the cell surface has been
described. The auxiliary 3 subunit, which is expressed in dor-
sal root ganglia (DRG) neurons, associates with the -subunit of
voltage-gated sodiumchannels [48], andplays akey role in thispro-rotein–protein interactions.
∗ Corresponding author.
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Open access under CC BY license.cess. The intracellular C-terminus of the 3 subunit directly binds
the portion of NaV1.8 containing the RRR signal [54] (Fig. 1). This
interaction masks the retention signal and leads to the release of
the channel fromtheER.Other sodiumchannels also containpoten-
tial ER retention signals, although the position of this motif is not
conserved (e.g. NaV1.5 – RKR amino acid 480–482). Hence, simi-
lar mechanisms to control retention/trafﬁcking to the membrane
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Fig. 1. Structureof theNaV1.8 showing the fourhomologousdomains, eachofwhich
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Ss composed of six membrane spanning segments. The S4 voltage sensors are shown
npink. Thebinding sites for theNaV1.8-interactingproteinsare shown.Theﬁvesites
or PKA phosphorylation at serine residues are indicated as “P”.
ould exist for the other sodium channel isoforms. It is known the
3 subunit is up-regulated in small diameter neurons upon nerve
xotomy [48], chronic constriction injury [41] and, in medium size
eurons, in diabetic neuropathy models [42]. Thus, the 3 sub-
nit mediated NaV1.8 release from the ER could also account for
ncreased excitability in pain states due to additional NaV1.8 being
ransported onto the cell membrane.
. p11
Although the 3 subunit has been shown to help translocation
f NaV1.8 from ER to the plasma membrane as described above, we
ound that co-expression of accessory -subunits did not help the
unctional NaV1.8 expression in heterologous cells such as COS [3].
his suggested that NaV1.8 requires other accessory proteins for
ts functional expression on the plasma membrane and led to the
iscovery of p11 as a novel permissive factor for NaV1.8 [32]. p11
S100A10, Annexin 2 light chain) is a member of the S100 calcium
inding protein family, which regulates many cellular processes
n response to intracellular calcium changes. p11 is expressed in
large number of tissues and is present in many regions of the
NS including the cerebral cortex, hippocampus andhypothalamus
38,55]. It exists as a tight, non-covalent dimer and is the onlymem-
er of family to have suffered mutations within its EF hand motifs,
endering it Ca2+ insensitive [19]. Although p11 cannot respond to
alcium ﬂuctuations, it exists in a permanently “activated state”
ompared to other members of the S100 family [18]. The major-
ty of p11 present intracellularly, exists as a heterotetramer (A2t),
omposed of two identical annexin II heavy chains [19]. Annexin
I, interacts in a Ca2+-dependent manner with negatively charged
hospholipids, alsobinding tocholesterol andmanyprotein ligands
ncluding actin, and is thought to be involved in many membrane-
elated events including endosomemembrane trafﬁcking along the
ecycling and degradation pathways [23,2]. The phosphorylation
y PKC of Ser11 of Annexin II disrupts p11 binding [20], while the
ctivationof aproteinphosphatasebyPKAand subsequentdephos-
horylation of the same residue [34] may allow coupling of the
11 localisation to theCa2+ andcAMP-dependent cellular signalling
athways.
Both yeast two-hybrid and GST pull-down assays demonstrate
hat p11 binds to the amino terminus of NaV1.8, especially resides
4–103, located close to the start of the initial transmembrane
omain [30] (Fig. 1). Upon co-expression of p11 with NaV1.8 in
eterologous cells such as CHO, the channel successfully translo-
ated to the plasma membrane [32] (Fig. 2), even in the absence
f additional -subunits. In DRGs, in the absence of p11 (DRG spe-
iﬁc knock-out), poor functional NaV1.8 expression is observed [9].
nterestingly, since functional expression is not totally abolished
n the knock-out, additional factors expressed speciﬁcally by neu-
ons, may be capable of trafﬁcking a small amount of the channel.
igniﬁcantly, p11 binds only to NaV1.8 and not to the other sodiume Letters 486 (2010) 78–83 79
channel subtypes also expressed in nociceptive neurons, such as
NaV1.7 and NaV1.9 [33].
The identiﬁcation of p11 as a chaperone protein for NaV1.8
has been followed by discoveries of many other membrane pro-
teins controlled by p11 including TASK-1, 5-HT1B receptors, ASIC-1,
TrpV5, and TrpV6. p11 promotes the membrane localisation of
TASK-1 by masking an ER retention signal at the end of the C-
terminal of the channel [13]. Interestingly p11 has also been
reported to act as an ER retention factor by binding to the other
region of the C-terminal of TASK-1 [35]. At present the ability of
p11 to act either ER retention factor or translocation promoterwith
different proteins is not understood. There is evidence to suggest
that the carboxy terminus of p11 itself,may contain an ER retention
motif, and thus interaction with other proteins may subsequently
lead to ER retention [35]. Additionally, p11 could itself interactwith
other proteins masking their ER retention motifs, blocking their
effect and subsequently releasing the protein from the ER.
3. PDZD2
PDZD2, also known as Papin, AIPC and PDZK3, is a large protein
(2766 amino acid), which was identiﬁed as an interactor of NaV1.8
using the yeast two-hybrid system [30]. PDZD2 contains six PDZ
domains, four located at theN-terminus and two at the C-terminus,
and is thought to act as a scaffoldingprotein assisting the trafﬁcking
and/or clustering of target proteins [22]. PDZD2 is expressed in sev-
eral tissues including heart, lung, pancreas and DRG [52]. In DRGs,
PDZD2 is expressed in both small peripherin positive and large
NF200 positive neurons [44]. PDZD2 has been shown to directly
bind the second intracellular loop of NaV1.8 (between domain II
and III) through its C-terminus (Fig. 1). Antisense mRNA and siRNA
mediated knock-down of PDZD2 in DRG neurons in vitro leads to a
drastic reduction of NaV1.8 mediated sodium currents [44] (Fig. 3).
Whether PDZD2 regulates the trafﬁcking or the retention of NaV1.8
within the membrane has not yet been addressed. PDZD2 has also
been shown to bind NaV1.7 and, may bind to all voltage-gated
sodium channels via conserved PDZ binding motifs [44,45]. The
binding of PDZD2 to NaV1.8 and NaV1.7 (which together underlie
action potential generation and propagation in unmyelinated noci-
ceptive ﬁbres) suggests that PDZD2 may modulate cell excitability
andultimatelypain thresholds. The roleof PDZD2 inpain sensitivity
has been investigated in PDZD2 knock-out mice, however no alter-
ations in pain behaviours were observed (mechanical, thermal and
inﬂammatory pain models) [44]. The absence of a pain phenotype
could be explained by the up-regulation of p11 that occurs in these
mice, which could mask PDZD2 effects by increasing the amount
of membrane associated NaV1.8 [44]. Interestingly, the assump-
tion that NaV1.8 is solely expressed in DRG has been challenged
by the discovery that both mouse and human atria and ventricles
contain mRNA for NaV1.8 and signiﬁcantly a mutation in the chan-
nel is linked to cardiac problems [6]. This mutation V1073A in the
second intracellular loop of NaV1.8, is ﬂanked by a putative phos-
phorylation site (RKDS) and a class I PDZ binding motif. As both
PDZD2 and syntrophin-associated serine/threonine kinase (SASTK)
have been shown to bind this intracellular loop [30] (Fig. 1), inter-
action with these molecules may be linked to the trafﬁcking and
electrophysiological properties of NaV1.8.
4. ContactinContactin is a glycosyl-phosphatidylinositol-anchored CAM
protein expressed by neurons. Reports show that it co-
immunoprecipitates with sodium channels from the brain and
enhances NaV1.2 currents when co-expressed with 1 subunit in a
heterologous system [21]. Also, the interaction between Contactin,
80 R.S. Swanwick et al. / Neuroscience Letters 486 (2010) 78–83
Fig. 2. (a) NaV1.8-like immunoreactivity in CHO-SNS22 cells. (b) Transient expression of GFP-p11 fusion protein in CHO-SNS22 cell. (c) Merged picture of (a) and (b) showing
co-expression of p11 and NaV1.8 in the plasma membrane. (d and e) Microscopic images were quantitated using the NIH Image program. Densitometric measurements show
the clear translocation of NaV1.8 into the plasma membrane in GFP-p11 transfected cells.
Reproduced, with permission, from Ref. [32].
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Pig. 3. (a) PDZD2antisensemRNAexpression inDRGneurons caused a loss ofNaV1.8
nto cultured DRG neurons caused efﬁcient and speciﬁc down-regulation of endog
eduction of the NaV1.8 current density in DRG neurons. (d) Example TTX-resistant i
eproduced, with permission, from Ref. [44].
1 subunit, and Ankyrin is required to keep NaV1.2 at high den-
ity on the cell membrane [28]. Further to this, Contactin binds
o NaV1.3, resulting in increased sodium peak currents without
hanging the electrophysiological properties of the channel [43]. In
ddition, Contactin regulatesNaV1.8 andNaV1.9mediated currents
37]. In Contactin knock-out mice, tetrodotoxin-resistant currents
re decreased while tetrodotoxin-sensitive currents are unaltered
n unmyelinated DRG neurons. In these animals the NaV1.8 activa-
ion curvewas shifted to amore depolarised potential (i.e. a greater
epolarisation is needed for activation) but no changeswere appar-
nt for NaV1.9. Contactin deﬁcient mice also exhibit a reduction of
aV1.8 and NaV1.9 (but not of NaV1.6 and NaV1.7) immunoreactiv-
ty along unmyelinated axons in the sciatic nerve, suggesting a role
f Contactin in regulating the surface expression of these channels.
. PGE2-dependent trafﬁcking to the plasma membrane
It is well established that during inﬂammatory conditions
everal compounds such as prostaglandin E2 (PGE2), adenosine
riphosphate, Bradykinin, nerve growth factor and histamine acti-
ate intracellular cascades resulting in sensitisation of nerve
erminals and lowered pain thresholds. Among these compounds,
GE2, a derivate of arachidonic acid, binds to its receptors, EP2 andnt density. (b) Transfection of PDZD2-speciﬁc siRNA (conjugated toAlexa Fluor-488)
PDZD2 protein expression. (c) The transfection of PDZD2 siRNA caused signiﬁcant
current traces from negative control siRNA and PDZD2 siRNA treated DRG neurons.
EP4, which in turn activate intracellular Protein kinase A (PKA)
(reviewed in Refs. [31,25]). PKA phosphorylates serine residues
within the intracellular loop I of NaV1.8 and alters its gating prop-
erties, shifting its steady-state activation curve to a more negative
potential [8] (Fig. 4). This change may account for an increase
in NaV1.8 mediated sodium currents and higher cell excitability.
However, increased trafﬁcking of NaV1.8 to the cell membrane
has recently been discovered to substantially contribute to this
phenomenon [27]. It has been demonstrated that PGE2 directly
promotes surface expression of NaV1.8 in a dose-dependent man-
ner, and this effect can be blocked by cellular trafﬁcking inhibitors.
Forskolin, an activator of PKA, increases the NaV1.8 density on
the membrane and mutation of the phosphorylation sites (RXXS)
on NaV1.8 abolishes forskolin mediated effects. Interestingly, this
effect of PKA phosphorylation is dependent on the ER retention
motif RRR (whose sequence is shared with a phosphorylation site),
but is independent of the masking effect of the 3 subunit men-
tioned above.6. CAP-1A
Endocytosis is known to regulate the surface presentation of
many membrane proteins. Sodium channels have been demon-
82 R.S. Swanwick et al. / Neuroscience Letters 486 (2010) 78–83
Fig. 4. Comparison of voltage-dependence of current activation in wild-type NaV1.8 (WT) and the mutant NaV1.8 (SA) which lacks ﬁve PKA consensus phosphorylation
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mites within the intracellular loop between domain I and II. Representative currents
ransfected with mutant NaV1.8 (SA) are shown. The current–voltage plots shows d
aV1.8 expressed cells. Closed circle – NaV1.8 (WT); open circle – NaV1.8 (SA).
eproduced, with permission, from Ref. [8].
trated to be selectively degraded in acidic/lysosomal vesicles upon
nfection of DRG neurons by herpes simplex virus [47]. Using the
-terminus of NaV1.8 as bait in yeast two-hybrid screens, CAP-1A
Clathrin-associated protein-1A) was identiﬁed as a binding part-
er [26]. CAP-1A is thought tobind toa conservedmotif alsopresent
n other sodium channels such NaV1.2 [11] and act as an adaptor
rotein, linking voltage-gated sodium channels to clathrin, which
s involved in coated vesicle assembly. Calmodulin binding to an
Q motif within the C-terminus has been proposed to disrupt CAP-
A binding and subsequently inhibit its cell surface removal by the
ndocytic pathway [7].
. Local translation
There is a growing body of evidence suggesting that local trans-
ation, where transcription is distal from the ﬁnal location of
rotein synthesis, is an important mechanism regulating many cel-
ular functions. mRNA transportation, localisation and subsequent
local translation” is thought to be especially important in highly
olarised cells, including neurons, where a rapid response to stim-
li would be limited by long distance protein transport. In neuronal
ells, it has been demonstrated to play a role in axonal growth
29], long-termpotentiation in the brain [5], synaptic plasticity [51]
nd to modulate pain threshold [17]. At present, “local synthesis”
f transmembrane proteins is controversial as their synthesis and
ost-translational modiﬁcations (e.g. glycosylation) requires both
R and Golgi at the location of synthesis, although tantalising evi-
ence suggests that some membrane proteins can be synthesised
ocally such as GluR and IP3RI, where these membrane proteins are
xpressed along dendrites and at the synapses respectively [46,15].
A recent study has investigated the potential involvement of
ocal translation on NaV1.8 protein changes in a model on neu-
opathic pain [50]. Upon sciatic nerve entrapment it has been
ound that compound action potential and NaV1.8 immunoreactiv-
ty increased in the treated nerve. Concomitantwith these ﬁndings,
aV1.8 mRNA level was up-regulated in the sciatic nerve but
emained unchanged in the DRG, while no changes were detected
or the mRNAs of other channel isoforms. It has been proposed that
peciﬁc and enhanced transport of NaV1.8 mRNA into the axons
ay account for this up-regulation and that local mRNA accumu-ssociated current–voltage plots from a wild-type NaV1.8-transfected cell and a cell
e in peak current and right shift of voltage-dependence of activation in the mutant
lation could contribute to increased axonal NaV1.8 protein levels.
Recent evidence using rapamycin inhibition ofmTOR suggests that,
in DRG, A but not C-ﬁbre neurons contain the machinery to carry
out local translation [17]. Interestingly, a small subset of C-ﬁbres
may indeed be capable of local translation, although more work
needs to be carried out to conﬁrm this result. A recent study mea-
suring the axonal transport velocity of Kv1.2 recorded a rate of
0.8m/s [14]. Assuming this velocity is similar for sodium chan-
nels, the transportofmolecules to theextremeendsof theaxonmay
require many days. Plasma membrane inserted sodium channels
exhibit a half-life of around 50h and those within the intracellu-
lar pool signiﬁcantly less (∼30h) [39]. These values place an upper
limit on the distance the channels could diffuse or be actively trans-
ported to their destination.
Because of its involvement in pain pathways and tissue-speciﬁc
localisation, NaV1.8 has been one of the best studied sodium chan-
nels and expected to be a good target for the treatment of chronic
pain. Although many attempts have been made to develop spe-
ciﬁc blockers for NaV1.8 [10,16], the development of type-speciﬁc
blockers of individual sodium channels has remained challenging
due to the similarities among the sodium channels. Successful use
of gabapentin/pregabalin for the treatment of neuropathic pain
provided a new route to block channel activities, i.e. targeting
accessory subunits to inhibit the localisation of calcium channels to
the plasma membrane and/or to alter the activation kinetics [49].
The trafﬁckingmechanismsofNaV1.8 discussed abovemayprovide
such novel targets for the treatment of chronic pain.
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